Danel (Adir Yeoshua) Ltd (TLV:DANE)
51,160
-40 (-0.08%)
Oct 26, 2025, 1:04 PM IDT
Danel (Adir Yeoshua) Revenue
Danel (Adir Yeoshua) had revenue of 714.96M ILS in the quarter ending June 30, 2025, with 3.74% growth. This brings the company's revenue in the last twelve months to 2.84B, up 7.37% year-over-year. In the year 2024, Danel (Adir Yeoshua) had annual revenue of 2.77B with 10.20% growth.
Revenue (ttm)
2.84B
Revenue Growth
+7.37%
P/S Ratio
1.07
Revenue / Employee
660.86K
Employees
4,290
Market Cap
3.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.77B | 256.31M | 10.20% |
| Dec 31, 2023 | 2.51B | 149.89M | 6.34% |
| Dec 31, 2022 | 2.36B | 75.20M | 3.29% |
| Dec 31, 2021 | 2.29B | 303.89M | 15.31% |
| Dec 31, 2020 | 1.98B | 306.79M | 18.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 56.02B |
| Novolog (Pharm-Up 1966) | 2.04B |
| Ilex Medical | 927.57M |
| Kamada | 571.15M |
| InterCure | 243.12M |
| SofWave Medical | 234.12M |
| BrainsWay | 155.27M |
| Bait Bakfar | 106.25M |